239
Views
10
CrossRef citations to date
0
Altmetric
Original Research

More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study

, , , , , , , , , & ORCID Icon show all
Pages 7197-7206 | Published online: 27 Oct 2021

References

  • Coronavirus disease (COVID-19) pandemic [homepage on the Internet]. Geneva: World Health Organization; 2021. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed September 17, 2021.
  • Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES. Universal masking in hospitals in the Covid-19 era. N Engl J Med. 2020;382(21):e63. doi:10.1056/NEJMp2006372
  • Lee JK, Jeong HW. Wearing face masks regardless of symptoms is crucial for preventing the spread of COVID-19 in hospitals. Infect Control Hosp Epidemiol. 2020;42(1):115–116. doi:10.1017/ice.2020.202
  • Bhatla N, Singhal S. The COVID-19 pandemic and implications for gynaecologic cancer care. Indian J Gynecol Oncol. 2020;18(2):48. doi:10.1007/s40944-020-00395-7
  • Mlcochova P, Collier D, Ritchie A, et al. Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant. Cell Rep Med. 2020;1(6):100099. doi:10.1016/j.xcrm.2020.100099
  • Frey MK, Fowlkes RK, Badiner NM, et al. Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecol Oncol. 2020;159(2):470–475. doi:10.1016/j.ygyno.2020.09.005
  • Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat. 2020;184(1):249–254. doi:10.1007/s10549-020-05828-7
  • Sha Z, Chang K, Mi J, et al. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med. 2020;9(5):3373–3378. doi:10.21037/apm-20-1662
  • Li J, Santa-Maria CA, Feng H, et al. Patient-reported outcomes of patients with breast cancer during the COVID-19 outbreak in the epicenter of China: a cross-sectional survey study. Clin Breast Cancer. 2020;20(5):E651–E662. doi:10.1016/j.clbc.2020.06.003
  • Casco NC, Carmona MJ, Soto AJ. Therapeutic and surgical indications for patients with penile cancer in the COVID-19 era. Int Braz J Urol. 2020;46(suppl.1):86–92. doi:10.1590/s1677-5538.ibju.2020.s110
  • Shipe ME, Haddad DN, Deppen SA, Kozower BD, Grogan EL. Modeling the impact of delaying the diagnosis of non-small cell lung cancer during COVID-19. Ann Thorac Surg. 2020;19:248–254.
  • Lung Cancer Study Group CTSCMA, Chinese Respiratory Oncology C. Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of coronavirus disease 2019 (Trial version). Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(4):297–301.
  • Brissot E, Labopin M, Baron F, et al. Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2021;56(3):532–535. doi:10.1038/s41409-020-0970-x
  • Conforti C, Giuffrida R, Di Meo N, Zalaudek I. Management of advanced melanoma in the COVID-19 era. Dermatol Ther. 2020;33(4):e13444. doi:10.1111/dth.13444
  • Raghavan D, Tan AR, Story ES, et al. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic. Endocr Relat Cancer. 2020;27(9):E357–E374. doi:10.1530/ERC-20-0229
  • Assi T, Ibrahim N, Abboud RMK, et al. The management of patients with metastatic prostate cancer during the COVID-19 pandemic. Fut Oncol. 2020;16(20):1455–1462. doi:10.2217/fon-2020-0361
  • Salazar-Vega J, Ortiz-Prado E, Solis-Pazmino P, et al. Thyroid cancer in Ecuador, a 16 years population-based analysis (2001–2016). BMC Cancer. 2019;19(1):294. doi:10.1186/s12885-019-5485-8
  • Hoang JK, Nguyen XV, Davies L. Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol. 2015;22(8):1024–1029. doi:10.1016/j.acra.2015.01.019
  • O’Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011. Int J Cancer. 2015;137(11):2664–2673. doi:10.1002/ijc.29634
  • Davies L, Hoang JK. Thyroid cancer in the USA: current trends and outstanding questions. Lancet Diabetes Endocrinol. 2021;9(1):11–12. doi:10.1016/S2213-8587(20)30372-7
  • Morris LGT, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200(4):454–461. doi:10.1016/j.amjsurg.2009.11.008
  • Bresner L, Banach R, Rodin G, Thabane L, Ezzat S, Sawka AM. Cancer-related worry in Canadian thyroid cancer survivors. J Clin Endocrinol Metab. 2015;100(3):977–985. doi:10.1210/jc.2014-3169
  • Andersen JH, Jensen JC. Modern health worries and visits to the general practitioner in a general population sample: an 18 month follow-up study. J Psychosom Res. 2012;73(4):264–267. doi:10.1016/j.jpsychores.2012.07.007
  • Fenton JJ, Magnan EM, Jerant A, Kravitz RL, Franks P. Patient characteristics associated with making requests during primary care visits. J Am Board Fam Med. 2019;32(2):201–208. doi:10.3122/jabfm.2019.02.180218
  • Campenni A, Barbaro D, Guzzo M, Capoccetti F, Giovanella L. Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts. Endocrine. 2020;70(2):280–291. doi:10.1007/s12020-020-02418-x
  • Health Commission of Hubei Province. In extraordinary times, necessary diagnosis and treatment are guaranteed, Wuhan medical institutions are in action [homepage on the Internet]. Wuhan: Health Commission of Hubei Province; 2021. Available from: http://wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/fkdt/202002/t20200214_2027302.shtml. Accessed February 14, 2021.
  • Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587–595. doi:10.1016/j.jacr.2017.01.046
  • Tsang VHM, Gild M, Glover A, Clifton-Bligh R, Robinson BG. Thyroid cancer in the age of COVID-19. Endocr Relat Cancer. 2020;27(11):R407–R416. doi:10.1530/ERC-20-0279
  • Krishan K, Kanchan T. Lockdown is an effective ‘vaccine’ against COVID-19: a message from India. J Infect Dev Ctries. 2020;14(6):545–546. doi:10.3855/jidc.12931
  • Siqueira CA, de Freitas YNL, Cancela MD, Carvalho M, Oliveras-Fabregas A, de Souza DLB. The effect of lockdown on the outcomes of COVID-19 in Spain: an ecological study. PLoS One. 2020;15(7):e0236779. doi:10.1371/journal.pone.0236779
  • Qian Y, Hanser A. How did Wuhan residents cope with a 76-day lockdown? Chin Sociol Rev. 2020;53(1):55–86. doi:10.1080/21620555.2020.1820319
  • Smulever A, Abelleira E, Bueno F, Pitoia F. Thyroid cancer in the Era of COVID-19. Endocrine. 2020;70(1):1–5. doi:10.1007/s12020-020-02439-6
  • Vrachimis A, Iakovou I, Giannoula E, Giovanella L. Endocrinology in the time of COVID-19 management of thyroid nodules and cancer. Eur J Endocrinol. 2020;183(1):G41–G48. doi:10.1530/EJE-20-0269
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: a meta-analysis. Int J Surg. 2018;50:121–125. doi:10.1016/j.ijsu.2017.12.035
  • Park YM, Lee DY, Oh KH, et al. Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma. Oral Oncol. 2017;75:1–5. doi:10.1016/j.oraloncology.2017.10.012
  • Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of thyroid cancer: a review of the national cancer database, 2000–2013. Cureus. 2019;11(2):e4127.
  • Falcone R, Grani G, Ramundo V, et al. Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies. Front Oncol. 2020;10:1128. doi:10.3389/fonc.2020.01128
  • Akula SM, Abrams SL, Steelman LS, et al. Cancer therapy and treatments during COVID-19 era. Adv Biol Regul. 2020;77:100739. doi:10.1016/j.jbior.2020.100739
  • Kim TY, Shong YK. Active surveillance of papillary thyroid microcarcinoma: a mini-review from Korea. Endocrinol Metab. 2017;32(4):399–406. doi:10.3803/EnM.2017.32.4.399
  • Tuttle RM, Ahuja S, Avram AM, et al. Controversies, consensus, and collaboration in the use of I-131 therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29(4):461–470.
  • Shaha AR. Thyroid surgery during COVID-19 pandemic: principles and philosophies. Head Neck. 2020;42(6):1322–1324. doi:10.1002/hed.26198
  • Campenni A, Giovanella L, Siracusa M, et al. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? Thyroid. 2014;24(11):1607–1611. doi:10.1089/thy.2014.0217
  • Campenni A, Ruggeri RM, Siracusa M, et al. Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer. Eur J Endocrinol. 2021;185(3):397–404. doi:10.1530/EJE-21-0328